Back to Aberdeen Group plc Aberdeen Group plc

PVLAPVLA
4 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in Palvella Therapeutics, Inc.

Aberdeen Group plc holds 120,238 shares of PVLA (Palvella Therapeutics, Inc.), worth $18.4M as of 2026-Q2. The position was increased (+48.3% shares). PVLA represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$18.4M

Current Shares

120,238

Total Value Change

+$15.2M

Total Shares Change

+68,995

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
120,238
+48.3%
$18.4M0.0%$152.82
39
2026-Q1
New
81,081
-
$10.1M0.0%$131.51
38
2025-Q4
Exited
0
-100.0%
$00.0%$99.88
0
2025-Q3
New
51,243
-
$3.2M0.0%$62.25
37

Other major holders of PVLA: JENNISON ASSOCIATES LLC, BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used